Lung cancer treatment could be made more effective by a new development.
Scientists at the University of Strathclyde bypassed the complications caused by intravenous treatment – which can include kidney damage – by using a nebuliser.
The device allows the drugs to quickly reach the lungs and also means doctors can reduce dosage size without losing any of the drug's effectiveness.
"It would make the treatment far less onerous for them and we hope it would help them to live longer," said Dr Chris Carter, a senior lecturer from the Strathclyde Institute of Pharmacy and Biomedical Sciences.
She stated that it is vital to find treatments for the disease as lung cancer is one of Scotland's biggest killers.
Cancer Research UK states the low survival rates associated with this form of the disease can be largely attributed to the fact that current treatments are ineffective against the later stages of lung cancer.
© Adfero Ltd
Cancer treatment news : 15 October 2011